Back
ProShares Ultra Gold Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
63
UGL
ProShares Ultra Gold
Last Price:
$135.00
Seasonality Move:
1.33%
Sell
50
RYTM
Rhythm Pharmaceuticals
Last Price:
$58.98
Seasonality Move:
54.9%
Buy
63
ProShares Ultra Gold (UGL)
is a Buy
Is ProShares Ultra Gold a Buy, Sell or Hold?
-
The current ProShares Ultra Gold [UGL] share price is $134.34. The Score for UGL is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
UGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $58.97. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UGL Stock Price Chart
What is ProShares Ultra Gold's stock price today?
-
The ProShares Ultra Gold share price today is $134.34The current trend is moderately bearish and UGL is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $58.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.
UGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.29 | Buy |
Relative Strength Index (14 RSI): | 47.59 | Sell |
Chaikin Money Flow: | 20864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (129.39 - 147.49) | Sell |
Bollinger Bands (100): | (99.15 - 132.41) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 46.88 | Sell |
Chaikin Money Flow: | 27337 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.61 - 64.05) | Sell |
Bollinger Bands (100): | (52.9 - 60.74) | Buy |
UGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 140.84 | Sell |
20-day SMA: | 141.89 | Sell |
50-day SMA: | 128.81 | Buy |
200-day SMA: | 104.35 | Buy |
8-day EMA: | 140.74 | Sell |
20-day EMA: | 139.1 | Sell |
50-day EMA: | 130.6 | Buy |
200-day EMA: | 107.64 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.08 | Sell |
20-day SMA: | 62.15 | Sell |
50-day SMA: | 56.78 | Buy |
200-day SMA: | 54.27 | Buy |
8-day EMA: | 61.17 | Sell |
20-day EMA: | 61 | Sell |
50-day EMA: | 58.76 | Buy |
200-day EMA: | 53.68 | Buy |
ProShares Ultra Gold Earnings Growth & UGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
ProShares Ultra Gold Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |